These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
136 related items for PubMed ID: 21353281
1. Amino acid changes within the E protein hinge region that affect dengue virus type 2 infectivity and fusion. Butrapet S, Childers T, Moss KJ, Erb SM, Luy BE, Calvert AE, Blair CD, Roehrig JT, Huang CY. Virology; 2011 Apr 25; 413(1):118-27. PubMed ID: 21353281 [Abstract] [Full Text] [Related]
2. Domain-III FG loop of the dengue virus type 2 envelope protein is important for infection of mammalian cells and Aedes aegypti mosquitoes. Erb SM, Butrapet S, Moss KJ, Luy BE, Childers T, Calvert AE, Silengo SJ, Roehrig JT, Huang CY, Blair CD. Virology; 2010 Oct 25; 406(2):328-35. PubMed ID: 20708768 [Abstract] [Full Text] [Related]
3. Glycosylation of the dengue 2 virus E protein at N67 is critical for virus growth in vitro but not for growth in intrathoracically inoculated Aedes aegypti mosquitoes. Bryant JE, Calvert AE, Mesesan K, Crabtree MB, Volpe KE, Silengo S, Kinney RM, Huang CY, Miller BR, Roehrig JT. Virology; 2007 Sep 30; 366(2):415-23. PubMed ID: 17543367 [Abstract] [Full Text] [Related]
4. Changes in the dengue virus major envelope protein on passaging and their localization on the three-dimensional structure of the protein. Lee E, Weir RC, Dalgarno L. Virology; 1997 Jun 09; 232(2):281-90. PubMed ID: 9191841 [Abstract] [Full Text] [Related]
5. Determinants in the envelope E protein and viral RNA helicase NS3 that influence the induction of apoptosis in response to infection with dengue type 1 virus. Duarte dos Santos CN, Frenkiel MP, Courageot MP, Rocha CF, Vazeille-Falcoz MC, Wien MW, Rey FA, Deubel V, Desprès P. Virology; 2000 Sep 01; 274(2):292-308. PubMed ID: 10964773 [Abstract] [Full Text] [Related]
6. Comparison of sequences of E/NS1 gene junction of dengue type 3 virus following culture subpassage in C6/36 cells to study the possible occurrence of mutations. Thayan R, Morita K, Vijayamalar B, Zainah S, Chew TK, Oda K, Sinniah M, Igarashi A. Southeast Asian J Trop Med Public Health; 1997 Jun 01; 28(2):380-6. PubMed ID: 9444025 [Abstract] [Full Text] [Related]
7. The dengue virus type 2 envelope protein fusion peptide is essential for membrane fusion. Huang CY, Butrapet S, Moss KJ, Childers T, Erb SM, Calvert AE, Silengo SJ, Kinney RM, Blair CD, Roehrig JT. Virology; 2010 Jan 20; 396(2):305-15. PubMed ID: 19913272 [Abstract] [Full Text] [Related]
8. Essential role of dengue virus envelope protein N glycosylation at asparagine-67 during viral propagation. Mondotte JA, Lozach PY, Amara A, Gamarnik AV. J Virol; 2007 Jul 20; 81(13):7136-48. PubMed ID: 17459925 [Abstract] [Full Text] [Related]
9. Differences between cell membrane fusion activities of two dengue type-1 isolates reflect modifications of viral structure. Desprès P, Frenkiel MP, Deubel V. Virology; 1993 Sep 20; 196(1):209-19. PubMed ID: 8356794 [Abstract] [Full Text] [Related]
10. Isolation and characterization of two phenotypically distinct dengue type-2 virus isolates from the same dengue hemorrhagic Fever patient. Kinoshita H, Mathenge EG, Hung NT, Huong VT, Kumatori A, Yu F, Parquet MC, Inoue S, Matias RR, Natividad FF, Morita K, Hasebe F. Jpn J Infect Dis; 2009 Sep 20; 62(5):343-50. PubMed ID: 19762982 [Abstract] [Full Text] [Related]
12. Epitope determinants of a chimpanzee Fab antibody that efficiently cross-neutralizes dengue type 1 and type 2 viruses map to inside and in close proximity to fusion loop of the dengue type 2 virus envelope glycoprotein. Goncalvez AP, Purcell RH, Lai CJ. J Virol; 2004 Dec 20; 78(23):12919-28. PubMed ID: 15542644 [Abstract] [Full Text] [Related]
13. Detection and sequencing of defective viral genomes in C6/36 cells persistently infected with dengue virus 2. Juárez-Martínez AB, Vega-Almeida TO, Salas-Benito M, García-Espitia M, De Nova-Ocampo M, Del Ángel RM, Salas-Benito JS. Arch Virol; 2013 Mar 20; 158(3):583-99. PubMed ID: 23129130 [Abstract] [Full Text] [Related]
14. The envelope glycoproteins of dengue 1 and dengue 2 viruses grown in mosquito cells differ in their utilization of potential glycosylation sites. Johnson AJ, Guirakhoo F, Roehrig JT. Virology; 1994 Sep 20; 203(2):241-9. PubMed ID: 8053148 [Abstract] [Full Text] [Related]
15. Identification of mutations in a candidate dengue 4 vaccine strain 341750 PDK20 and construction of a full-length cDNA clone of the PDK20 vaccine candidate. Kelly EP, Puri B, Sun W, Falgout B. Vaccine; 2010 Apr 09; 28(17):3030-7. PubMed ID: 19874927 [Abstract] [Full Text] [Related]
16. A small molecule fusion inhibitor of dengue virus. Poh MK, Yip A, Zhang S, Priestle JP, Ma NL, Smit JM, Wilschut J, Shi PY, Wenk MR, Schul W. Antiviral Res; 2009 Dec 09; 84(3):260-6. PubMed ID: 19800368 [Abstract] [Full Text] [Related]
17. Deglycosylation of the NS1 protein of dengue 2 virus, strain 16681: construction and characterization of mutant viruses. Crabtree MB, Kinney RM, Miller BR. Arch Virol; 2005 Apr 09; 150(4):771-86. PubMed ID: 15592895 [Abstract] [Full Text] [Related]
18. Construction of infectious cDNA clones for dengue 2 virus: strain 16681 and its attenuated vaccine derivative, strain PDK-53. Kinney RM, Butrapet S, Chang GJ, Tsuchiya KR, Roehrig JT, Bhamarapravati N, Gubler DJ. Virology; 1997 Apr 14; 230(2):300-8. PubMed ID: 9143286 [Abstract] [Full Text] [Related]
20. [Recombinant envelope glycoprotein domain III of dengue virus inhibit virus infection]. Lu P, Wei Y, Cao SC, Li JD, Liu QZ, Zhang QF, Li C, Miao F, Zhang S, Hang XT, Liang MF, Li DX. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Jun 14; 22(3):177-9. PubMed ID: 19031695 [Abstract] [Full Text] [Related] Page: [Next] [New Search]